Puma Biotechnology, Inc. (PBYI) Posts Q2 Loss of $1.05/Share

Puma Biotechnology, Inc. (NYSE: PBYI) reported Q2 EPS of ($1.05), $0.39 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
• Keurig Dr Pepper coffee chief to depart ahead of planned split